WASHINGTON (AP) — U.S. officials on Monday approved the first long-acting drug to protect babies and toddlers against a respiratory virus that sends tens of thousands of American children to the hospital each year.
RSV is a cold-like nuisance for most healthy people, but it can be life-threatening in the very young and the elderly.
The Food and Drug Administration approved the injection for infants and children up to 2 years old who face increased risk of severe RSV.
Branson Schools Announces New Executive Director of Operations
Pioneering Quality in the Steel Industry
Can a Contractor Take Over Your Home
Frozen Pipes, Hot Water Heaters, and Dishwasher Mishaps
Choosing the Right Trailer: A Comprehensive Guide